CODEXIS

Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development. Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms. Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA
CODEXIS
Industry:
Biotechnology Chemical Sustainability
Founded:
2002-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.codexis.com
Total Employee:
51+
Status:
Active
Contact:
650-421-8100
Total Funding:
162 M USD
Technology used in webpage:
IPv6 ASP.NET Amazon S3 Microsoft Java EE Apple Whitelist Amazon Oregon Region Amazon Frankfurt Region Entrust EV Entrust SSL
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Board_member
Current Employees Featured
Asli Aras VP & Head of Corporate Development @ Codexis
VP & Head of Corporate Development
2021-11-01
Aaron Hammons Senior Director of Business Development, Americas @ Codexis
Senior Director of Business Development, Americas
2020-02-01
Rob Wilson SVP & General Manager, Performance Enzymes @ Codexis
SVP & General Manager, Performance Enzymes
2020-12-01
David O'Toole Senior Vice President and Chief Financial Officer @ Codexis
Senior Vice President and Chief Financial Officer
2012-09-01
Stephen Dilly President, CEO and Board member @ Codexis
President, CEO and Board member
2022-01-01
Karen Frechou-Armijo SVP & Head of Human Resources @ Codexis
SVP & Head of Human Resources
2021-11-01
James Lalonde Senior Vice President, Research & Development @ Codexis
Senior Vice President, Research & Development
2004-07-01
Ivan Labat Senior Scientist @ Codexis
Senior Scientist
2011-06-01
Douglas Sheehy Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary @ Codexis
Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary
2007-04-01
Gordon Sangster CFO @ Codexis
CFO
2014-08-01
Founder
Stock Details
Investors List
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Codexis
Pequot Capital
Pequot Capital investment in Series D - Codexis
CMEA Capital
CMEA Capital investment in Series D - Codexis
EDBI
EDBI investment in Series D - Codexis
Chevron Technology Ventures
Chevron Technology Ventures investment in Series D - Codexis
Maxygen
Maxygen investment in Series D - Codexis
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-29 | seqWell | Codexis investment in Series C - seqWell | 7 M USD |
2022-03-15 | Molecular Assemblies | Codexis investment in Series B - Molecular Assemblies | 25.8 M USD |
2021-04-15 | Molecular Assemblies | Codexis investment in Series A - Molecular Assemblies | 11.8 M USD |
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-07-18 | Codexis Announces CEO Transition Effective August 9, 2022 |
2021-11-15 | Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development |
Official Site Inspections
http://www.codexis.com Semrush global rank: 1.1 M Semrush visits lastest month: 29.7 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Codexis"
Codexis - Wikipedia
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function. See details»
Corporate Governance :: Codexis, Inc. (CDXS)
As a retired CFO of DataStax, Inc. and previously as executive vice president and CFO of Fusion-io Multisystems and MySQL AB, Dennis Wolf brings significant experience in financial …See details»
Codexis Org Chart + Executive Team - The Official Board
The org chart of Codexis contains its 16 main executives including Stephen Dilly, Georgia Erbez and Kevin Norrett.See details»
Board of Directors :: Codexis, Inc. (CDXS)
Raymond De Vré brings over 20 years of executive-level experience to Codexis. He currently serves as the Chief Executive Officer and Managing Director at RADV Advisory, an …See details»
Codexis - Crunchbase Company Profile & Funding
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.See details»
Codexis - The Org
Codexis, Inc. is a leading protein engineering company applying innovative technologies to Unlock the Power of Proteins™.See details»
www.codexis.com
We would like to show you a description here but the site won’t allow us.See details»
Codexis' Leadership Team Team - Team members and org chart
The leadership team at Codexis has experience in the animal health, dental, and medical technology industries.See details»
Codexis (LON:0I0X) Company Profile & Description - Stock Analysis
Company profile for Codexis, Inc. (LON:0I0X) with a description, list of executives, contact details and other key facts.See details»
Codexis, Inc.: Governance, Directors and Executives & Committees ...
Feb 21, 2014 Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high …See details»
Codexis, Inc. - LinkedIn
Codexis, Inc. | 17,799 followers on LinkedIn. We deliver exquisite enzymes for the betterment of human health. | Codexis is a leading enzyme engineering company leveraging its proprietary …See details»
Codexis - Overview, News & Similar companies | ZoomInfo.com
Feb 12, 2024 View Codexis (www.codexis.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Codexis Announces Byron Dorgan to Retire from Board of Directors
Apr 9, 2025 Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver ® technology platform to …See details»
Codexis Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Codexis has 5 employees at their 1 location and $59.35 m in annual revenue in FY 2024. See insights on Codexis including office locations, competitors, revenue, financials, …See details»
Codexis Inc Company Profile - Overview - GlobalData
Codexis Inc (Codexis) is a protein engineering company that discovers, develops and markets synthetic proteins for a wide range of applications. It sells biocatalysts for the commercial …See details»
Codexis - Funding, Financials, Valuation & Investors
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.See details»
Codexis Announces Byron Dorgan to Retire from Board of Directors
Apr 9, 2025 With this change, Codexis will reduce the number of seats on its Board of Directors from ten to nine. About Codexis Codexis is a leading provider of enzymatic solutions for …See details»
Jobs at Codexis Inc | Codexis Inc Careers
At Codexis, we engineer enzymes for biosolutions that benefit human health and environmental health. From developing biocatalysts for sustainable pharmaceutical manufacturing, to …See details»
Codexis Announces First Revenue-Generating Contract for ECO
Mar 24, 2025 Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to …See details»
Codexis Announces First Revenue-Generating Contract for ECO
Mar 25, 2025 Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently …See details»